Common antibiotic may shield kidney patients from dangerous Post-Hospital infections
NCT ID NCT07224997
Summary
This study is testing whether a common antibiotic (trimethoprim-sulfamethoxazole, also known as Bactrim) can prevent infections in adults who are leaving the hospital after experiencing acute kidney injury. About 120 participants will be randomly assigned to take either the antibiotic or a placebo pill every other day for 90 days after going home. Researchers will track them for 6 months to see if the antibiotic reduces infections, hospital readmissions, and other health problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY (AKI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.